AU2001292936A1 - Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines - Google Patents
Octahydro-indolizines and quinolizines and hexahydro-pyrrolizinesInfo
- Publication number
- AU2001292936A1 AU2001292936A1 AU2001292936A AU9293601A AU2001292936A1 AU 2001292936 A1 AU2001292936 A1 AU 2001292936A1 AU 2001292936 A AU2001292936 A AU 2001292936A AU 9293601 A AU9293601 A AU 9293601A AU 2001292936 A1 AU2001292936 A1 AU 2001292936A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrrolizines
- quinolizines
- indolizines
- octahydro
- hexahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23450400P | 2000-09-22 | 2000-09-22 | |
US23450500P | 2000-09-22 | 2000-09-22 | |
US60/234,504 | 2000-09-22 | ||
US60/234,505 | 2000-09-22 | ||
PCT/US2001/029624 WO2002024695A2 (en) | 2000-09-22 | 2001-09-21 | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001292936A1 true AU2001292936A1 (en) | 2002-04-02 |
Family
ID=26928022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292936A Abandoned AU2001292936A1 (en) | 2000-09-22 | 2001-09-21 | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
Country Status (6)
Country | Link |
---|---|
US (4) | US20030013733A1 (en) |
EP (1) | EP1326863A2 (en) |
JP (1) | JP2004510712A (en) |
AU (1) | AU2001292936A1 (en) |
CA (1) | CA2423284A1 (en) |
WO (1) | WO2002024695A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0224557D0 (en) * | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
AU2003287206A1 (en) | 2002-10-23 | 2004-05-13 | Janssen Pharmaceutica, N.V. | Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
EA009860B1 (en) | 2002-10-23 | 2008-04-28 | Янссен Фармацевтика, Н.В. | Piperazinyl and diazapanyl benzamides and benzthioamides |
GB0229822D0 (en) * | 2002-12-20 | 2003-01-29 | Glaxo Group Ltd | Novel compounds |
DK1773345T3 (en) * | 2004-06-30 | 2014-03-24 | Athersys Inc | NON-imidazol-tertiary amines AS HISTAMINE-3 receptor inhibitors in treating cognitive disorders, sleep disorders, obesity and other CNS DISORDERS |
JP5185120B2 (en) | 2005-09-16 | 2013-04-17 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Cyclopropylamine as modulator of histamine H3 receptor |
FR2906251B1 (en) * | 2006-09-22 | 2008-11-07 | Sanofi Aventis Sa | PYRROLIZINE, INDOLIZINE AND QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF |
KR101129868B1 (en) * | 2006-10-04 | 2012-04-12 | 화이자 프로덕츠 인코포레이티드 | Pyrido[4,3-d]pyrimidin-43h-one derivatives as calcium receptor antagonists |
WO2011043954A1 (en) * | 2009-10-07 | 2011-04-14 | Merck Sharp & Dohme Corp. | Novel trpa1 antagonists |
US8143273B2 (en) * | 2010-06-22 | 2012-03-27 | Hoffman-La Roche Inc. | Quinolizidine and indolizidine derivatives |
JP5973990B2 (en) * | 2011-03-16 | 2016-08-23 | 武田薬品工業株式会社 | Fused heterocyclic compounds |
TW201311679A (en) | 2011-08-04 | 2013-03-16 | Takeda Pharmaceutical | Nitrogen-containing heterocyclic compound |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
CN103242212B (en) * | 2013-05-13 | 2015-11-04 | 南京理工大学 | A kind of brain histamine H 3precursor of Receptor Radioligand and preparation method thereof |
EP3134404A1 (en) | 2014-04-25 | 2017-03-01 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2447587A (en) * | 1942-12-18 | 1948-08-24 | Geigy Ag J R | Acyl glycine amides |
US4689329A (en) * | 1986-02-04 | 1987-08-25 | Mcneilab, Inc. | 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates |
US4683239A (en) * | 1986-04-10 | 1987-07-28 | Mcneilab, Inc. | 3-diphenyl substituted octahydroindolizine analgesic compounds |
US5352707A (en) * | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
US5217986A (en) * | 1992-03-26 | 1993-06-08 | Harbor Branch Oceanographic Institution, Inc. | Anti-allergy agent |
US5869479A (en) * | 1997-08-14 | 1999-02-09 | Schering Corporation | Treatment of upper airway allergic responses |
EP0978512A1 (en) * | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications |
-
2001
- 2001-09-21 AU AU2001292936A patent/AU2001292936A1/en not_active Abandoned
- 2001-09-21 US US09/960,031 patent/US20030013733A1/en not_active Abandoned
- 2001-09-21 WO PCT/US2001/029624 patent/WO2002024695A2/en active Application Filing
- 2001-09-21 EP EP01973346A patent/EP1326863A2/en not_active Withdrawn
- 2001-09-21 JP JP2002529105A patent/JP2004510712A/en not_active Withdrawn
- 2001-09-21 CA CA002423284A patent/CA2423284A1/en not_active Abandoned
-
2004
- 2004-02-06 US US10/773,808 patent/US20040167336A1/en not_active Abandoned
-
2005
- 2005-08-17 US US11/205,958 patent/US20050288323A1/en not_active Abandoned
-
2009
- 2009-06-30 US US12/494,754 patent/US20090263322A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090263322A1 (en) | 2009-10-22 |
JP2004510712A (en) | 2004-04-08 |
CA2423284A1 (en) | 2002-03-28 |
WO2002024695A3 (en) | 2002-09-19 |
US20040167336A1 (en) | 2004-08-26 |
US20030013733A1 (en) | 2003-01-16 |
US20050288323A1 (en) | 2005-12-29 |
WO2002024695A2 (en) | 2002-03-28 |
EP1326863A2 (en) | 2003-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
EG23122A (en) | Pyrrolcarboxamides and pyrrolcarbothioamides | |
AU9667901A (en) | Mycoattractants and mycopesticides | |
AU2001262847A1 (en) | Language-understanding | |
AU2001213236A1 (en) | Mini-cyclone biocollector and concentrator | |
AU2001280599A1 (en) | Compounds and methods | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2001253418A1 (en) | Compounds and methods | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2002211717A1 (en) | Stresscopins and their uses | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
AU2001243394A1 (en) | Compounds and methods | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
AUPQ872300A0 (en) | Compounds and methods | |
AU2001278951A1 (en) | Compounds and methods | |
AU2001246864A1 (en) | Hypotensors | |
AU4432001A (en) | Trityl-type compounds and their use | |
AU2002214354A1 (en) | Neck-phone | |
AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof | |
AU2002256556A1 (en) | Sea-trosy and related methods |